ALS researchers at Harvard uncover new biomarker and drug target

A mutated form of the gene that makes a protein called TDP-43 has been implicated in the brain disorder amyotrophic lateral sclerosis (ALS). New research out of Harvard has revealed a connection between TDP-43 and another gene—a link that could yield new approaches to treating the disease.